IL-33 as a biomarker for disease severity in COPD with lung cancer comorbidity

IL-33 levels were significantly higher in patients with comorbid COPD and lung cancer than in those with COPD alone. IL-33 was negatively correlated with lung function and positively correlated with GOLD Staging, suggesting its potential as a biomarker for disease severity.

Authors

Institutions

Publication Details

Journal
American Journal of Cancer Research
Published
2025-01-01
DOI
https://doi.org/10.62347/qcsn6467
Primary Topic
IL-33, ST2, and ILC Pathways
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

IL-33 as a biomarker for disease severity in COPD with lung cancer comorbidity

Hui Jun Ren
1 links
American Journal of Cancer Research
IL-33, ST2, and ILC Pathways
article

IL-33 as a biomarker for disease severity in COPD with lung cancer comorbidity

Hui Jun Ren
article en

Abstract

IL-33 levels were significantly higher in patients with comorbid COPD and lung cancer than in those with COPD alone. IL-33 was negatively correlated with lung function and positively correlated with GOLD Staging, suggesting its potential as a biomarker for disease severity.

American Journal of Cancer ResearchVol. 15(6)
Second Affiliated Hospital of Inner Mongolia Medical University (CN), Inner Mongolia Medical University (CN)
Inner Mongolia Medical University
Good health and well-being
Openalex Percentile: Top 83%
IL-33, ST2, and ILC Pathways
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.